Current development status of the second generation alkylphosphocholine analog perifosine

Drugs of Today

Volumn 34, Issue SUPPL. F, 1998, Pages 67-71

  Traiser, M ^a   Reichert, S ^a   Voss, A ^a  

^a ASTA MEDICA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE; PERIFOSINE; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TOLERABILITY; GASTROINTESTINAL TOXICITY; HUMAN; MAXIMUM PERMISSIBLE DOSE; NAUSEA; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; SIGNAL TRANSDUCTION; VOMITING;

EID: 0032428614     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Article

References (13)